Elevation of B-type natriuretic peptide is a sensitive marker of left ventricular diastolic dysfunction in patients with maintenance haemodialysis
Authors:
- 7 May 2010
- journal article
- Published by Taylor & Francis in Biomarkers
- Vol. 15 (6) , 533-537
Abstract
Objective: To determine the clinical value of B-type natriuretic peptide (BNP) in diagnosing left ventricular diastolic dysfunction (LVDD) associated with maintenance haemodialysis (MHD) population. Methods: Plasma BNP was determined in 59 MHD patients with normal ejection fraction. The ratio of early to late annular velocity (E’/A’) was determined by tissue Doppler imaging as a parameter of diastolic function. Results: LVDD occurred in 66% of the patients. Receiver-operating characteristic curve analyses identified a cut-off of 353.6 pg ml−1 as the one with the highest sensitivity and specificity for detecting LVDD. Conclusions: Plasma BNP may serve as a potential biomarker in diagnosing LVDD in MHD patients with normal systolic function.Keywords
This publication has 23 references indexed in Scilit:
- Reviews: Is Regression of Left Ventricular Hypertrophy in Maintenance Hemodialysis Patients Possible?Seminars in Dialysis, 2008
- BNP and a Renal Patient: Emphasis on the Unique Characteristics of B-Type Natriuretic Peptide in End-Stage Kidney Disease2008
- Brain Natriuretic Peptide in Hemodialysis Patients: Predictive Value for Hemodynamic Change during Hemodialysis and Cardiac FunctionAmerican Journal of Nephrology, 2007
- Adiponectin Is Associated with Brain Natriuretic Peptide and Left Ventricular Hypertrophy in Hemodialysis Patients with Type 2 Diabetes MellitusNephron Clinical Practice, 2007
- Chronic Kidney Disease Associated Mortality in Diastolic Versus Systolic Heart Failure: A Propensity Matched Study††The Digitalis Investigation Group study was conducted and supported by the National Heart, Lung, and Blood Institute in collaboration with the Digitalis Investigation Group Investigators. This manuscript was prepared using a limited access data set obtained by the National Heart, Lung, and Blood Institute and does not necessarily reflect the opinions or views of the Digitalis Investigation Group or the National Heart, Lung, and Blood Institute.The American Journal of Cardiology, 2007
- Value of B‐type natriuretic peptide in diagnosing left ventricular dysfunction in dialysis‐dependent patientsInternal Medicine Journal, 2006
- Chronic kidney disease: the global challengeThe Lancet, 2005
- Utility of B-Natriuretic Peptide in Detecting Diastolic DysfunctionCirculation, 2002
- Diagnostic potential of cardiac natriuretic peptides in dialysis patientsKidney International, 2001
- Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.Circulation, 1977